click below
click below
Normal Size Small Size show me how
Blood,Lymph&Immune
Spelling & Reverse Definitions
Question | Answer |
---|---|
adenopathy | Disease of a gland |
agranuloctye | Type of WBC without granules |
anemia | Reduction in the number of circulating RBC |
antiserum | Blood serum that contains antibodies |
autoimmune disease | Failure of the body to accurately distinguish between what is "self" and what is "non-self" |
basophil | Leukocyte that releases histamines and heparin; slightly phagocyic |
blood | Composed of liquid portion called plasma and solid portion containing RBCs, WBCs and platelets |
dyspnea | Difficulty breathing |
edema | Abnormal accumulation of fluids in the intercellular spaces of the body |
eosinophil | Leukocyte that protects the body by releasing toxins to destroy harmful invaders |
erythema | Redness of the skin |
erythrocyte | Mature red blood cell |
erythrocytolysis | Destruction of red blood cells |
erythropenia | Decreased red blood cells |
granulocyte | Type of WBC containing granules; formed in the red bone marrow |
hematopoiesis | Formation of blood cells and platelets in the bone marrow |
hemocytoblasy | Stem cell, from which other blood cells deelop |
hemoglobin | A specialized plasma protein containing iron which gives blood its red colour and also carries oxygen to body tissues |
hemophilia | A hereditary disorder in which there is an impairment of the blood clotting mechanism |
hemosiderosis | Abnormal increase of iron in the blood |
hypochromic | Pertaining to decrease of colour |
hypotension | Low blood pressure |
immunologist | One who specializes in the study of protection |
leukocyte | WBC; prevents invasion of foreign microorganisms |
leukocytosis | Abnormal increase of white cells |
leukopenia | Decrease in WBCs. |
lymphocytes | WBC in blood and lymphatis tissues; provides protection from bacteria |
lymphoma | Tumor of lymph tissue |
megakaryoctye | Cell with a large nucleus; fragments become platelets |
monocyte | Leukocyte that is phagocytic; has large nucleus |
morphology | The study of shape |
myeloblast | Embryonic WBC formed in bone marrow |
myeloid | Resembling bone marrow |
myeloid tissue | Tissue which resembles the myelocyte of bone marrow |
neutrophil | The most numerous white cell, highly phagocytic |
phagocytosis | Condition of ingesting cells |
phlebotomy | Obtaining blood for the purpose of testing |
plasma | The liquid portion of the blood where blood cells are suspended |
reticulocyte | Immature RBC |
splenomegaly | Enlargement of the spleen |
tachycardia | Rapid heart beat |
thrombocyte | Platelet; initiates blood clotting |
thrombocytopenia | Decrease of platelets |
thrombolysis | Destruction of a clot |
thymectomy | Removal/exision of the thymus gland |
vertigo | Dizziness |
viscous | Thick, sticky |
immunocompetent | Ability to develop an immune response or recognize antigens and respond to them |
DIC - disseminated intravascular coagulation | Abnormal activation of the proteins involved in blood coagulation, causing small blood clots to form in vessels and cutting off the supply of oxygen to distal tissues |
lymphadenopathy | Any disease of the lymph nodes |
hemoglobinopathy | Any disorder caused by abnormalities in the hemoglobin molecule |
immunotherapy | Any form of treatment that alters, enhances, stimulates or restores the body's natural immune mechanisms to treat disease |
von Willebrand disease | Bleeding disorder cause by a deficiency of von Willebrand factor, a "sticky" protein that lines blood vessels and reacts with platelets to form a plug that leads to clot formation |
cytokine | Chemical substance produced by certain cells that initiates, inhibits, increases or decreases activity of other cells |
pernicious anemia | Chronic, progressive anemia found mostly in people older than 50 due to lack of sufficient Vitamin B12 needed for blood cell development |
GVHD -graft-versus-host disease | Complication that occurs following a stem cell or bone marrow transplant in which the transplant produces antibodies against recipient's organs that can be severe enough to cause death |
antimicrobials | Destroy bacteria, fungi and protozoa, depending on the particular drug, generally by interfering with the functions of their cell membrane or their reproductive cycle |
hemolytic anemia | Destruction of RBCs, commonly resulting in jaundice |
thrombolytics | Dissolve blood clots by destroying their fibrin strands |
bone marrow MRI | Highly sensitive imaging procedure that detects lesions and changes in bone tissue and bone marrow, especially in multiple myeloma |
allergy injections | Injection with increasing strength of the offending antigen given over a period of months or years to increase tolerance to an antigen responsible for severe allergies |
folic-acid deficiency anemia | Inability to produce sufficient red blood cells due to lack of folic acid, a B vitamin essential for erythropoiesis |
transfusion | Infusion of blood or blood products from one person to another |
homologous BM transplant | Infusion of bone marrow or stem cells from a compatible donor after a course of chemotherapy and /or radiation; also called allogenic transplant |
bone marrow transplant | Infusion of healthy bone marrow stem cells after the diseased bone marrow is destroyed by chemotherapy and/or radiation therapy; used to treat leukemia, aplastic anemia and certain cancers |
autologous BM transplant | Infusion of the patient's own bone marrow or stem cells after a course of chemotherapy and/or radiation therapy |
sickle cell anemia | Inherited anemia that causes RBCs to become crescent or sickle-shaped when oxygen levels are low |
lymphoscintigraphy | Introduction of a radioactive tracer into the lymph channels to determine lymph flow, identify obstruction and locate the sentinel node |
iron-deficiency anemia | Lack of sufficient iron in RBCs |
hematoma | Localized accumulation of blood, usually clotted, in an organ, space or tissue due to a break in or severing of a blood vessel |
multiple myeloma | Malignant tumor or plasma cells in the bone marrow |
antifibrinolytics | Neutralize fibrinolytic chemicals in the mucous membranes of the mouth, nose and urinary tract to prevent the breakdown of blood clots |
monospot test | Nonspecific rapid serological test for the presence of the heterophile antibody, which develops several days after injection by Epstein-Barr virus, the organism that caused infectious mononucleosis |
thrombocythemia | Overproduction of platelets, leading to thrombosis or bleeding disorders due to platelet malformations |
sepsis | Presence of bacteria or their toxins in the blood; also called septicemia or blood poisoning |
fat-soluble vitamins | Prevent and treat bleeding disorders resulting from a lack of prothrombin, which is commonly caused by vitamin K deficiency |
anticoagulants | Prevent blood clot formation by inhibiting the synthesis or inactivating one or more clotting factors |
antivirals | Prevent replication of viruses within host cells |
graft rejection | Process in which a recipient's immune system attacks a transplanted organ or tissue |
Ab -antibody | Protective protein produced by B lymphocytes in response to the presence of a foreign substance called an antigen |
bone marrow aspiration | Removal of a small sample of bone marrow using a thin aspirating needle for microscopic examination |
lymphadenectomy | Removal of lymph nodes, especially in surgical procedures undertaken to remove malignant tissue |
sentinel node excision | Removal of the first lymph node that receives drainage from cancer-containing areas and the one most likely to contain malignant cells |
CBC -complete blood count | Series of tests that includes hemoglobin; hematocrit; read and white blood cell counts; platelet counts; and differential count; also called hemogram |
aplastic enemia | Serious forma of anemia associated with bone marrow failure and resulting in erythropenia, leukopenia and thrombocytopenia |
NK -natural killer cells | Specialized lymphocytes that kill abnormal cells by releasing chemicals that destroy the cell membrane, causing its intercellular fluids to leak out |
antigen | Substance, recognized as harmful to the host, that stimulates formation of antibodies in an immunocompetent individual |
bile pigment | Substances derived from the breakdown of hemoglobin and excreted by the liver |
lymphedema | Swelling, primarily in a single arm or leg, due to an accumulation of lymph within tissues caused by obstruction or disease in the lymph vessels |
PTT - partial thromboplastin time | Test that measures the length of time it takes blood to clot to screen for deficiencies of some clotting factors; also called activated partial thromboplastin time |
PT - prothrombin time | Test that measures the time it takes for prothrombin to form a clot; also called pro time |
blood culture | Test to determine the presence of pathogens in the bloodstream |
shilling test | Test used to diagnose pernicious anemia by determining if the body properly absorbs Vitamin B12 through the digestive tract |
ANA - antinuclear antibody | Test to identify antibodies that attack the nucleus of the individual's own body cells |
biological | Use of immune system stimulators to enhance the immune response in the treatment of certain forms of cancer, rheumatoid arthritis and Crohn disease; also called biologic therapy or biotherapy |
lymphangiography | Visualization of lymphatic channels and lymph nodes using a contrast medium to determine blockages or other pathologies of the lymph system |
SLE - systemic lupus erythematosus | Widespread autoimmune disease that may affect the skin, brain, kidneys and joints and causes chronic inflammation; also called discoid lupus if symptoms are limited to the skin |